Article (Scientific journals)
RENO, a European Postmarket Surveillance Registry, confirms effectiveness of coronary brachytheraypy in routine clinical practice.
Coen, V; Serruys, P; Sauerwein, W et al.
2003In International Journal of Radiation, Oncology, Biology, Physics, 55 (4), p. 1019-1026
Peer Reviewed verified by ORBi
 

Files


Full Text
reno, a europeen postmarket 55 2003.pdf
Author postprint (136.99 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
RENO; Restenosis; Coronary; Radiation
Abstract :
[en] Purpose: To assess, by a European registry trial, the clinical event rate in patients with discrete stenotic lesions of coronary arteries (de novo or restenotic) in single or multiple vessels (native or bypass grafts) treated with -radiation. Methods and Materials: Between April 1999 and September 2000, 1098 consecutive patients treated in 46 centers in Europe and the Middle East with the Novoste Beta-Cath System were included in Registry Novoste (RENO). Results: Six-month follow-up data were obtained for 1085 patients. Of 1174 target lesions, 94.1% were located in native vessels and 5.9% in a bypass graft; 17.7% were de novo lesions, 4.1% were restenotic, and 77.7% were in-stent restenotic lesions. Intravascular brachytherapy was technically successful in 95.9% of lesions. Multisegmental irradiation, using a manual pullback stepping maneuver to treat longer lesions, was used in 16.3% of the procedures. The in-hospital rate of major adverse cardiac events was 1.8%. At 6 months, the rate was 18.7%. Angiographic follow-up was available for 70.4% of the patients. Nonocclusive restenosis was seen in 18.8% and total occlusion in 5.7% of patients. A combined end point for late (30–180 days) definitive or suspected target vessel closure was reached in 5.4%, but with only 2% of clinical events. Multivariate analysis was performed for major adverse cardiac events and late thrombosis. Conclusion: Data obtained from the multicenter RENO registry study, derived from a large cohort of unselected consecutive patients, suggest that the good results of recent randomized controlled clinical trials can be replicated in routine clinical practice. © 2003 Elsevier Science Inc.
Disciplines :
Oncology
Hematology
Author, co-author :
Coen, V
Serruys, P
Sauerwein, W
Orecchia, R
Von Rottkay, P
COUCKE, Philippe  ;  C.H.U.V. Lausanne, Switzerland
Ehnert, M
Urban, P
Bonan, R
Levendag, P
Language :
English
Title :
RENO, a European Postmarket Surveillance Registry, confirms effectiveness of coronary brachytheraypy in routine clinical practice.
Publication date :
2003
Journal title :
International Journal of Radiation, Oncology, Biology, Physics
ISSN :
0360-3016
eISSN :
1879-355X
Publisher :
Elsevier Science, Tarrytown, United States - New York
Volume :
55
Issue :
4
Pages :
1019-1026
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 15 July 2009

Statistics


Number of views
63 (0 by ULiège)
Number of downloads
191 (0 by ULiège)

Scopus citations®
 
19
Scopus citations®
without self-citations
18
OpenCitations
 
38

Bibliography


Similar publications



Contact ORBi